AU2016349358B2 - Peptides and methods of treating endometriosis using the same - Google Patents
Peptides and methods of treating endometriosis using the same Download PDFInfo
- Publication number
- AU2016349358B2 AU2016349358B2 AU2016349358A AU2016349358A AU2016349358B2 AU 2016349358 B2 AU2016349358 B2 AU 2016349358B2 AU 2016349358 A AU2016349358 A AU 2016349358A AU 2016349358 A AU2016349358 A AU 2016349358A AU 2016349358 B2 AU2016349358 B2 AU 2016349358B2
- Authority
- AU
- Australia
- Prior art keywords
- pif
- seq
- sample
- peptide
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPCT/US2015/058877 | 2015-11-03 | ||
| PCT/US2015/058877 WO2016073513A1 (en) | 2014-11-03 | 2015-11-03 | Pif binding as a marker for immune dysregulation |
| US201662317628P | 2016-04-03 | 2016-04-03 | |
| US62/317,628 | 2016-04-03 | ||
| PCT/US2016/060319 WO2017079430A1 (en) | 2015-11-03 | 2016-11-03 | Peptides and methods of treating endometriosis using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016349358A1 AU2016349358A1 (en) | 2018-06-14 |
| AU2016349358B2 true AU2016349358B2 (en) | 2019-12-05 |
Family
ID=58663080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016349358A Ceased AU2016349358B2 (en) | 2015-11-03 | 2016-11-03 | Peptides and methods of treating endometriosis using the same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3377085A4 (de) |
| AU (1) | AU2016349358B2 (de) |
| CA (1) | CA3004055A1 (de) |
| IL (1) | IL259096A (de) |
| WO (1) | WO2017079430A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017039751A1 (en) | 2015-08-28 | 2017-03-09 | Bioincept, Llc | Mutant peptides and methods of treating subjects using the same |
| EP3341006A4 (de) | 2015-08-28 | 2019-03-13 | BioIncept LLC | Zusammensetzungen und verfahren zur behandlung von nervenschäden |
| US20200246424A1 (en) * | 2017-07-17 | 2020-08-06 | Bioincept, Llc | Peptides and methods of transplantation and restorative organ function |
| CA3120699A1 (en) * | 2018-11-21 | 2020-05-28 | Endomet Biosciences, Inc. | Compositions and methods for treating endometriosis |
| CN113845582B (zh) * | 2021-10-15 | 2022-05-27 | 南京市妇幼保健院 | 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 |
| EP4248985A1 (de) * | 2022-03-25 | 2023-09-27 | Consejo Superior de Investigaciones Científicas (CSIC) | Peptide für die behandlung von retinitis pigmentosa |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646003A (en) * | 1994-03-23 | 1997-07-08 | Barnea; Eytan R. | Preimplantation factor |
| WO2000063675A1 (en) * | 1999-04-16 | 2000-10-26 | Bioincept, Inc. | Identification of a serum marker for endometriosis |
| US20080003178A1 (en) * | 2003-10-22 | 2008-01-03 | Barnea Eytan R | PIF tetrapeptides |
| US20150125886A9 (en) * | 2003-10-22 | 2015-05-07 | Biolncept, Llc | Compositions and methods for modulating the immune system |
| WO2016073513A1 (en) * | 2014-11-03 | 2016-05-12 | Bioincept, Llc | Pif binding as a marker for immune dysregulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970496B1 (de) * | 2013-03-12 | 2018-07-18 | Institute of Arthritis Research LLC | Immunologisch aktives polypeptid |
| WO2014201118A2 (en) * | 2013-06-11 | 2014-12-18 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
-
2016
- 2016-11-03 WO PCT/US2016/060319 patent/WO2017079430A1/en not_active Ceased
- 2016-11-03 CA CA3004055A patent/CA3004055A1/en not_active Abandoned
- 2016-11-03 AU AU2016349358A patent/AU2016349358B2/en not_active Ceased
- 2016-11-03 EP EP16862963.2A patent/EP3377085A4/de not_active Withdrawn
-
2018
- 2018-05-02 IL IL259096A patent/IL259096A/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646003A (en) * | 1994-03-23 | 1997-07-08 | Barnea; Eytan R. | Preimplantation factor |
| WO2000063675A1 (en) * | 1999-04-16 | 2000-10-26 | Bioincept, Inc. | Identification of a serum marker for endometriosis |
| US20080003178A1 (en) * | 2003-10-22 | 2008-01-03 | Barnea Eytan R | PIF tetrapeptides |
| US20150125886A9 (en) * | 2003-10-22 | 2015-05-07 | Biolncept, Llc | Compositions and methods for modulating the immune system |
| WO2016073513A1 (en) * | 2014-11-03 | 2016-05-12 | Bioincept, Llc | Pif binding as a marker for immune dysregulation |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017079430A1 (en) | 2017-05-11 |
| EP3377085A1 (de) | 2018-09-26 |
| EP3377085A4 (de) | 2019-07-17 |
| AU2016349358A1 (en) | 2018-06-14 |
| IL259096A (en) | 2018-06-28 |
| CA3004055A1 (en) | 2017-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016349358B2 (en) | Peptides and methods of treating endometriosis using the same | |
| US20250000942A1 (en) | Peptides and methods of transplantation and restorative organ function | |
| US20250152665A1 (en) | Mutant Peptides And Methods Of Treating Subjects Using The Same | |
| AU2019202741A1 (en) | Compositions and methods for treating acute radiation syndrome | |
| EP1401467B3 (de) | Alpha-fetoprotein-peptide und ihre verwendung | |
| US6818741B2 (en) | Alpha-fetoprotein peptides and uses therof | |
| US20240358791A1 (en) | Peptides and methods of treating dystrophy-related disorders using the same | |
| CA2965973A1 (en) | Pif binding as a marker for immune dysregulation | |
| EP1879604B1 (de) | Pif-tetrapeptide | |
| US7122522B2 (en) | Alpha-fetoprotein peptides and uses thereof | |
| US20250170212A1 (en) | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders | |
| US20110269692A1 (en) | Alpha-fetoprotein peptides and uses thereof | |
| EP4066850A2 (de) | Peptide und verfahren zur behandlung von dystrophiebedingten erkrankungen damit | |
| US7132400B2 (en) | Alpha-fetoprotein peptides and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |